Stocksigma LogoStocksigma Logo

India Glycols Outlines Cost Apportionment for Bio Pharma and Spirits Demergers

Pursuant to the NCLT-sanctioned Scheme of Arrangement effective 1st Sep'26, India Glycols Limited completed the demerger of its Bio Pharma and Spirits

India Glycols Outlines Cost Apportionment for Bio Pharma and Spirits Demergers

India Glycols Ltd 路 Others (Uncategorized) 路 06 Oct 2026, 11:32 pm

India Glycols Outlines Cost Apportionment for Bio Pharma and Spirits Demergers Pursuant to the NCLT-sanctioned Scheme of Arrangement effective 1st Sep'26, India Glycols Limited completed the demerger of its Bio Pharma and Spirits & Biofuel undertakings into Ennature Bio Pharma Limited and IGL Spirits Limited, respectively. For determining post-demerger acquisition costs under tax regulations, original acquisition costs are apportioned as 31.77% to India Glycols Limited, 20.61% to Ennature Bio Pharma Limited, and 47.62% to IGL Spirits Limited. Share entitlement ratios were 1:3 for Ennature Bio Pharma and 1:1 for IGL Spirits against existing holdings as of 2nd Sep'26.

Original exchange filing (PDF)

More announcements from India Glycols Ltd

All India Glycols Ltd announcements